Modulight Biotherapeutics
United States
- Boston, Massachusetts
- 13/11/2025
- Seed
- $12,000,000
Modulight Biotherapeutics is developing a transformative optogenetic platform that precisely targets pathological neural activity when and where it occurs to restore balance in the nervous system.
- Industry Biotechnology Research
- Website https://www.modulight.bio/
- LinkedIn https://www.linkedin.com/company/modulight-bio/
Related People
Yotam EldarFounder
United States -
Boston, Massachusetts
Experienced leader of operational and technology teams, with a passion for solving complex multidisciplinary problems in a data-driven and results-oriented manner, to achieve a solid and positive impact in the world.
Long track record of excellence across several fields and industries - from leading complex special operations and projects, through medical practice, to biotech innovation.
Currently Yotam is focused on building a transformative solution for intractable neurological conditions, utilizing his deep technical understanding, creativity, leadership and networking skills to create a truly meaningful, positive change for patients.
iDEL Therapeutics GmbH | $10,381,635 | (Mar 18, 2026)
Surf AI(1) | $57,000,000 | (Mar 18, 2026)
R1 Therapeutics | $77,500,000 | (Mar 18, 2026)
Quorus | $5,000,000 | (Mar 18, 2026)
BambooBox | $6,600,000 | (Mar 18, 2026)
Conduit Health | $17,000,000 | (Mar 18, 2026)
SEQUENTIAL | $3,500,000 | (Mar 18, 2026)
Standard Template Labs | $49,000,000 | (Mar 18, 2026)
Tenkara | $7,000,000 | (Mar 18, 2026)
Turquoise(US) | $40,000,000 | (Mar 18, 2026)
Malama Health | $9,200,000 | (Mar 17, 2026)
AgZen | $10,000,000 | (Mar 17, 2026)